All Stories

  1. Genotyping and distribution of Giardia intestinalis assemblages in NSW, Australia
  2. Multi-criteria decision making and its application to in silico discovery of vaccine candidates for Toxoplasma gondii
  3. Diagnostic dilemma: application of real-time PCR assays for the detection of Dientamoeba fragilis in medical and veterinary specimens
  4. What’s so special about special issues: Highlighting a central role of parasitology to support specific innovations and advance progress within our discipline
  5. Control of Intracellular Parasites: The Coccidia
  6. Celebrating 150 volumes of Parasitology with an outlook towards 2030 production
  7. Observations on the transmission of Dientamoeba fragilis and the cyst life cycle stage
  8. Bibliometric analysis of parasite vaccine research from 1990 to 2019
  9. A state-of-the-art methodology for high-throughput in silico vaccine discovery against protozoan parasites and exemplified with discovered candidates for Toxoplasma gondii
  10. A guide to current methodology and usage of reverse vaccinology towards in silico vaccine discovery
  11. Molecular Detection of Neglected Tropical Diseases: The Case for Automated Near–Point-of-Care Diagnosis of Leishmaniasis
  12. Twitter trends in #Parasitology determined by text mining and topic modelling
  13. Laboratory diagnostics for human Leishmania infections: a polymerase chain reaction-focussed review of detection and identification methods
  14. Transitioning to Open Access: Parasitology's Focus on Global Accessibility and Research Integrity
  15. Compilation of parasitic immunogenic proteins from 30 years of published research using machine learning and natural language processing
  16. Host transmission dynamics of first- and third-stage Angiostrongylus cantonensis larvae in Bullastra lessoni
  17. Predicting Protein Therapeutic Candidates for Bovine Babesiosis Using Secondary Structure Properties and Machine Learning
  18. Applying Machine Learning to Predict the Exportome of Bovine and Canine Babesia Species That Cause Babesiosis
  19. A new subspecies of Trypanosoma cyclops found in the Australian terrestrial leech Chtonobdella bilineata
  20. Machine learning and applications in microbiology
  21. Plasmodium falciparum Histidine-Rich Protein 2 and 3 Gene Deletions in Strains from Nigeria, Sudan, and South Sudan
  22. Recent trends in the use of social media in parasitology and the application of alternative metrics
  23. The controversies surrounding Giardia intestinalis assemblages A and B
  24. Species diversity and genome evolution of the pathogenic protozoan parasite, Neospora caninum
  25. Computational Antigen Discovery for Eukaryotic Pathogens Using Vacceed
  26. 30 years of parasitology research analysed by text mining
  27. Research into Neospora caninum—What Have We Learnt in the Last Thirty Years?
  28. A review of the systematics, species identification and diagnostics of the Trypanosomatidae using the maxicircle kinetoplast DNA: from past to present
  29. Molecular Detection of Antimalarial Drug Resistance in Plasmodium vivax from Returned Travellers to NSW, Australia during 2008–2018
  30. Contribution of introns to the species diversity associated with the apicomplexan parasite, Neospora caninum
  31. Detecting sequence variants in clinically important protozoan parasites
  32. Semi-Quantitative, Duplexed qPCR Assay for the Detection of Leishmania spp. Using Bisulphite Conversion Technology
  33. Diversity profiling of xenic cultures of Dientamoeba fragilis following systematic antibiotic treatment and prospects for genome sequencing
  34. Evolutionary Insight into the Trypanosomatidae Using Alignment-Free Phylogenomics of the Kinetoplast
  35. Identification of Clinical Infections of Leishmania Imported into Australia: Revising Speciation with Polymerase Chain Reaction-RFLP of the Kinetoplast Maxicircle
  36. Molecular detection of drug resistant malaria in Southern Thailand
  37. Angiostrongylus cantonensis: a review of its distribution, molecular biology and clinical significance as a human pathogen – CORRIGENDUM
  38. Evaluation of the EasyScreen Protozoan Detection Kit for the diagnosis of Entamoeba histolytica
  39. The complete coding region of the maxicircle as a superior phylogenetic marker for exploring evolutionary relationships between members of the Leishmaniinae
  40. Comparison and Recommendations for Use of Dientamoeba fragilis Real-Time PCR Assays
  41. Traveller sentinels for global surveillance of malaria drug resistance and diagnostic test evasion
  42. Annotating the ‘hypothetical’ in hypothetical proteins: In-silico analysis of uncharacterised proteins for the Apicomplexan parasite, Neospora caninum
  43. Epidemiology and associated risk factors of giardiasis in a peri-urban setting in New South Wales Australia
  44. Genome Wide Identification of Mutational Hotspots in the Apicomplexan Parasite Neospora caninum and the Implications for Virulence
  45. A Gene-Based Positive Selection Detection Approach to Identify Vaccine Candidates Using Toxoplasma gondii as a Test Case Protozoan Pathogen
  46. Resistance screening and trend analysis of imported falciparum malaria in NSW, Australia (2010 to 2016)
  47. Evolutionary ARMS Race: Antimalarial Resistance Molecular Surveillance
  48. On the application of reverse vaccinology to parasitic diseases: a perspective on feature selection and ranking of vaccine candidates
  49. The evolution of trypanosomatid taxonomy
  50. Dynamic island model based on spectral clustering in genetic algorithm
  51. Differential Gamma Interferon- and Tumor Necrosis Factor Alpha-Driven Cytokine Response Distinguishes Acute Infection of a Metatherian Host with Toxoplasma gondii and Neospora caninum
  52. Staged heterogeneity learning to identify conformational B-cell epitopes from antigen sequences
  53. Isolation of Novel Trypanosomatid, Zelonia australiensis sp. nov. (Kinetoplastida: Trypanosomatidae) Provides Support for a Gondwanan Origin of Dixenous Parasitism in the Leishmaniinae
  54. Mathematical Modeling and Control of Infectious Diseases
  55. Bulky Trichomonad Genomes: Encoding a Swiss Army Knife
  56. Detection of Dientamoeba fragilis in animal faeces using species specific real time PCR assay
  57. Angiostrongylus cantonensis: a review of its distribution, molecular biology and clinical significance as a human pathogen
  58. Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel
  59. Naturally acquired immunity to malaria
  60. Comparison of enteric protozoan infections in four Australian hospitals: variable tests and variable results
  61. Descriptive epidemiology of infectious gastrointestinal illnesses in Sydney, Australia, 2007–2010
  62. The Transcriptome Sequence of Dientamoeba fragilis Offers New Biological Insights on its Metabolism, Kinome, Degradome and Potential Mechanisms of Pathogenicity
  63. The Prevalence of Angiostrongylus cantonensis/mackerrasae Complex in Molluscs from the Sydney Region
  64. In VitroAntimicrobial Susceptibility Patterns of Blastocystis
  65. Recent Advances in Molecular Biology of Parasitic Viruses
  66. Improving the gene structure annotation of the apicomplexan parasite Neospora caninum fulfils a vital requirement towards an in silico-derived vaccine
  67. Molecular Epidemiology of Imported Cases of Leishmaniasis in Australia from 2008 to 2014
  68. A live vaccine against Neospora caninum abortions in cattle
  69. Positive-unlabeled learning for the prediction of conformational B-cell epitopes
  70. Developing and Evaluating an Accessible Cyberteaching Training (ACT) Program for Faculty via a Virtual Center for Teaching and Learning
  71. Enhancing In Silico Protein-Based Vaccine Discovery for Eukaryotic Pathogens Using Predicted Peptide-MHC Binding and Peptide Conservation Scores
  72. Influenza A HA's conserved epitopes and broadly neutralizing antibodies: A prediction method
  73. Epidemiology and geographical distribution of enteric protozoan infections in Sydney, Australia
  74. Discovering a vaccine against neosporosis using computers: is it feasible?
  75. Tertiary structure-based prediction of conformational B-cell epitopes through B factors
  76. Description of Dientamoeba fragilis Cyst and Precystic Forms from Human Samples
  77. Vacceed: a high-throughput in silico vaccine candidate discovery pipeline for eukaryotic pathogens based on reverse vaccinology
  78. Control options forNeospora caninum– is there anything new or are we going backwards?
  79. Evaluation of the EasyScreen™ Enteric Parasite Detection Kit for the detection of Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis from clinical stool samples
  80. Update on the pathogenic potential and treatment options for Blastocystis sp
  81. Activity of benzimidazoles againstDientamoeba fragilis(Trichomonadida, Monocercomonadidae)in vitroand correlation of beta-tubulin sequences as an indicator of resistance
  82. Update on the Molecular Epidemiology and Diagnostic Tools for Blastocystis sp
  83. Treatment failure in patients with chronic Blastocystis infection
  84. Cyst formation and faecal–oral transmission of Dientamoeba fragilis – the missing link in the life cycle of an emerging pathogen
  85. Subtype distribution of Blastocystis isolates from a variety of animals from New South Wales, Australia
  86. Prevalence of gastrointestinal pathogens in developed and developing countries: systematic review and meta-analysis
  87. What is the global economic impact of Neospora caninum in cattle – The billion dollar question
  88. Gastrointestinal pathogen distribution in symptomatic children in Sydney, Australia
  89. A review of the infection, genetics, and evolution of Neospora caninum: From the past to the present
  90. A novel strategy for classifying the output from an in silico vaccine discovery pipeline for eukaryotic pathogens using machine learning algorithms
  91. Current treatment options for Dientamoeba fragilis infections
  92. Evaluating High-Throughput Ab Initio Gene Finders to Discover Proteins Encoded in Eukaryotic Pathogen Genomes Missed by Laboratory Techniques
  93. On the Efficacy and Safety of Vaccination with Live Tachyzoites of Neospora caninum for Prevention of Neospora-Associated Fetal Loss in Cattle
  94. A guide to in silico vaccine discovery for eukaryotic pathogens
  95. Subtype distribution of Blastocystis isolates identified in a Sydney population and pathogenic potential of Blastocystis
  96. The Core Mouse Response to Infection by Neospora Caninum Defined by Gene Set Enrichment Analyses
  97. - Entamoeba
  98. Enteric Protozoa in the Developed World: a Public Health Perspective
  99. Oocysts and high seroprevalence of Neospora caninum in dogs living in remote Aboriginal communities and wild dogs in Australia
  100. New advances in thein-vitroculture ofDientamoeba fragilis
  101. A microscopic description and ultrastructural characterisation of Dientamoeba fragilis: An emerging cause of human enteric disease
  102. Detection and Transmission of Dientamoeba fragilis from Environmental and Household Samples
  103. In VitroSusceptibility Testing of Dientamoeba fragilis
  104. Prevalence of gastrointestinal pathogens in Sub-Saharan Africa: systematic review and meta-analysis
  105. A case-controlled study of Dientamoeba fragilis infections in children
  106. Implications of wild dog ecology on the sylvatic and domestic life cycle of Neospora caninum in Australia
  107. The ambiguous life ofDientamoeba fragilis: the need to investigate current hypotheses on transmission
  108. Comparison of Microscopy, Culture, and Conventional Polymerase Chain Reaction for Detection of Blastocystis sp. in Clinical Stool Samples
  109. A review ofDientamoeba fragiliscarriage in humans: Several reasons why this organism should be considered in the diagnosis of gastrointestinal illness
  110. Extensive production of Neospora caninum tissue cysts in a carnivorous marsupial succumbing to experimental neosporosis
  111. Microarray analyses of mouse responses to infection by Neospora caninum identifies disease associated cellular pathways in the host response
  112. Evaluation of Multiplex Tandem Real-Time PCR for Detection of Cryptosporidium spp., Dientamoeba fragilis, Entamoeba histolytica, and Giardia intestinalis in Clinical Stool Samples
  113. Importance of Nonenteric Protozoan Infections in Immunocompromised People
  114. Newly defined conditions for thein vitrocultivation and cryopreservation ofDientamoeba fragilis: new techniques set to fast track molecular studies on this organism
  115. Australian dingoes are definitive hosts of Neospora caninum
  116. The first report of ovine cerebral neosporosis and evaluation of Neospora caninum prevalence in sheep in New South Wales
  117. A Review of the Clinical Presentation of Dientamoebiasis
  118. On the Biological and Genetic Diversity in Neospora caninum
  119. Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples
  120. A second generation multiplex PCR for typing strains of Neospora caninum using six DNA targets
  121. Repeated Dientamoeba fragilis infections: a case report of two families from Sydney, Australia
  122. Isolation of Toxoplasma gondii from the brain of a dog in Australia and its biological and molecular characterization
  123. Clinical Significance of Enteric Protozoa in the Immunosuppressed Human Population
  124. Repeated Dientamoeba fragilis infections: a case report of two families from Sydney, Australia
  125. Neospora caninum – How close are we to development of an efficacious vaccine that prevents abortion in cattle?
  126. Genetic diversity amongst isolates of Neospora caninum, and the development of a multiplex assay for the detection of distinct strains
  127. Limited genetic diversity among genotypes of Enterocytozoon bieneusi strains isolated from HIV-infected patients from Sydney, Australia
  128. Protozoal Hepatitis Associated with Immunosuppressive Therapy in a Dog
  129. A unique thioredoxin of the parasitic nematode Haemonchus contortus with glutaredoxin activity
  130. Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model)
  131. Re-evaluating the economics of neosporosis control
  132. The development and evaluation of a nested PCR assay for detection of Neospora caninum and Hammondia heydorni in feral mouse tissues
  133. Thioredoxins of a parasitic nematode: Comparison of the 16- and 12-kDA thioredoxins from Haemonchus contortus
  134. Comparison of Stool Antigen Detection Kits to PCR for Diagnosis of Amebiasis
  135. Gorillas are a host for Dientamoeba fragilis: An update on the life cycle and host distribution
  136. Entamoeba moshkovskii infections in Sydney, Australia
  137. Laboratory Diagnostic Techniques for Entamoeba Species
  138. Neosporosis and hammondiosis in dogs
  139. Amoebiasis: current status in Australia
  140. PREVALENCE OF ENTERIC PROTOZOA IN HUMAN IMMUNODEFICIENCY VIRUS (HIV)–POSITIVE AND HIV-NEGATIVE MEN WHO HAVE SEX WITH MEN FROM SYDNEY, AUSTRALIA
  141. PCR Detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in Stool Samples from Sydney, Australia
  142. Dientamoeba fragilis as a Cause of Travelers’ Diarrhea: Report of Seven Cases: Table 1
  143. Irritable bowel syndrome: A review on the role of intestinal protozoa and the importance of their detection and diagnosis
  144. Immunization of Cattle with Live Tachyzoites of Neospora caninum Confers Protection against Fetal Death
  145. Prevalence of Neospora caninum infection in Australian (NSW) dairy cattle estimated by a newly validated ELISA for milk
  146. If control of Neospora caninum infection is technically feasible does it make economic sense?
  147. Locally acquired infection with Entamoeba histolytica in men who have sex with men in Australia
  148. Performance characteristics and optimisation of cut-off values of two enzyme-linked immunosorbent assays for the detection of antibodies to Neospora caninum in the serum of cattle
  149. Dientamoebiasis: clinical importance and recent advances
  150. Evaluation of Three Diagnostic Methods, Including Real-Time PCR, for Detection of Dientamoeba fragilis in Stool Specimens
  151. Hammondia isolated from dogs and foxes are genetically distinct
  152. Attachment and invasion of Toxoplasma gondii and Neospora caninum to epithelial and fibroblast cell lines in vitro
  153. Subcellular fractionation and molecular characterization of the pellicle and plasmalemma of Neospora caninum
  154. Prospective Study of the Prevalence, Genotyping, and Clinical Relevance of Dientamoeba fragilis Infections in an Australian Population
  155. Reduction in transplacental transmission of Neospora caninum in outbred mice by vaccination
  156. Culture of Neospora caninum in the presence of a Mycoplasma Removal Agent results in the selection of a mutant population of tachyzoites
  157. Application of bioinformatics to parasitology
  158. Neospora abortions in dairy cattle: diagnosis, mode of transmission and control
  159. AUTOFLUORESCENCE OF TOXOPLASMA GONDII AND NEOSPORA CANINUM CYSTS IN VITRO
  160. Detection of Dientamoeba fragilis in fresh stool specimens using PCR
  161. Microarrays and stage conversion in Toxoplasma gondii
  162. The cell-mediated immune response to Neospora caninum during pregnancy in the mouse is associated with a bias towards production of interleukin-4
  163. In Vitro Induction of Neospora caninum Bradyzoites in Vero Cells Reveals Differential Antigen Expression, Localization, and Host-Cell Recognition of Tachyzoites and Bradyzoites
  164. An outbreak of abortion in a dairy herd associated with Neospora caninum and bovine pestivirus infection
  165. The Design and Analysis of Microarray Experiments: Applications in Parasitology
  166. HAMMONDIA HEYDORNI FROM THE ARABIAN MOUNTAIN GAZELLE AND RED FOX IN SAUDI ARABIA
  167. Genomics and Its Impact on Parasitology and the Potential for Development of New Parasite Control Methods
  168. Hammondia heydornioocysts in the faeces of a greyhound in New Zealand
  169. Characterisation of the first Australian isolate of Neospora caninum from cattle
  170. Neospora caninum: a cause of immune-mediated failure of pregnancy?
  171. CHARACTERIZATION OF AN OUTBRED PREGNANT MOUSE MODEL OF NEOSPORA CANINUM INFECTION
  172. Redescription of Neospora caninum and its differentiation from related coccidia
  173. Control options forNeospora caninuminfections in cattle — current state of knowledge
  174. A previously unclassified trypanosomatid responsible for human cutaneous lesions in Martinique (French West Indies) is the most divergent member of the genus Leishmania ss
  175. Ribosomal DNA spacer genotypes of the Anopheles bancroftii group (Diptera: Culicidae) from Australia and Papua New Guinea
  176. Isolation of Neospora caninum genes detected during a chronic murine infection
  177. A Phylogenetic Study of the Anopheles punctulatus Group of Malaria Vectors Comparing rDNA Sequence Alignments Derived from the Mitochondrial and Nuclear Small Ribosomal Subunits
  178. Molecular Phylogeny of Besnoitia and the Genetic Relationships Among Besnoitia of Cattle, Wildebeest and Goats
  179. Subset partitioning of the ribosomal DNA small subunit and its effects on the phylogeny of the Anopheles punctulatus group
  180. Differential ecology of Anopheles punctulatus and three members of the Anopheles farauti complex of mosquitoes on Guadalcanal, Solomon Islands, identified by PCR-RFLP analysis
  181. Evidence for a neotropical origin of Leishmania
  182. The Leishmania major RNA Polymerase II Largest Subunit Lacks a Carboxy-Terminus Heptad Repeat Structure and its Encoding Gene is Linked with the Calreticulin Gene
  183. Seroprevalence ofNeospora caninuminfection following an abortion outbreak in a dairy cattle herd
  184. Isolation, characterization and expression of a GRA2 homologue from Neospora caninum
  185. Progress in the Serodiagnosis of Neospora caninum Infections of Cattle
  186. Populations of the south-west Pacific malaria vector Anopheles farauti s.s. revealed by ribosomal DNA transcribed spacer polymorphisms
  187. Development of a single tube nested polymerase chain reaction assay for the detection of Neospora caninum DNA
  188. The relationship of Hammondia hammondi and Sarcocystis mucosa to other heteroxenous cyst-forming coccidia as inferred by phylogenetic analysis of the 18S SSU ribosomal DNA sequence
  189. In vitro isolation of Neospora caninum from a stillborn calf in the UK
  190. DNA sequence analysis of the ribosomal DNA ITS2 region for the Anopheles punctulatus group of mosquitoes
  191. The genus Hammondia is paraphyletic
  192. Comparison of the biological characteristics of two isolates of Neospora caninum
  193. Evolution of RuminantSarcocystis(Sporozoa) Parasites Based on Small Subunit rDNA Sequences
  194. Polymerase chain reaction approaches for the detection of Neospora caninum and Toxoplasma gondii
  195. Leishmania (Sauroleishmania): A Comment on Classification
  196. Comparison of the large subunit ribosomal DNA ofNeosporaandToxoplasmaand development of a new genetic marker for their differentiation based on the D2 domain
  197. The development of random DNA probes specific for Aeromonas salmonicida
  198. Prevalence of Antibodies to Neospora caninum in Different Canid Populations
  199. Evolution of the genus Leishmania revealed by comparison of DNA and RNA polymerase gene sequences1Note: Nucleotide sequence data reported in this paper have been submitted to the GenBank™ data base with the accession numbers: POLA/RPOIILS (AF009134/AF0...
  200. Monophyletic origin of the genus Sauroleishmania
  201. Effects of nucleotide sequence alignment on phylogeny estimation: a case study of 18S rDNAs of apicomplexa
  202. Production of a recombinant fusion protein of Sarcocystis tenella and evaluation of its diagnostic potential in an ELISA
  203. Phylogenetic relationships between Leishmania, Viannia and Sauroleishmania inferred from comparison of a variable domain within the RNA polymerase II largest subunit gene
  204. A biochemical protocol for the differentiation of current genomospecies of Aeromonas
  205. Detection of Neospora caninum DNA by the polymerase chain reaction
  206. Differentiation ofAeromonasgenomospecies using random amplified polymorphic DNA polymerase chain reaction (RAPD-PCR)
  207. Phylogenetic relationships between Toxoplasma and Sarcocystis deduced from a comparison of 18S rDNA sequences
  208. Schistosoma mansoni: patterns of codon usage and bias
  209. Comparison of the patterns of codon usage and bias betweenBrugia, Echinococcus, Onchocerca andSchistosoma species
  210. Effects of sequence alignment on the phylogeny ofSarcocystis deduced from 18S rDNA sequences
  211. An empirical comparison of distance matrix techniques for estimating codon usage divergence
  212. Codon usage and bias among individual genes of the coccidia and piroplasms
  213. DNA polymerases of parasitic protozoa
  214. Lyme disease: a search for a causative agent in ticks in south–eastern Australia
  215. The phylogeny of Neospora caninum
  216. Contributions to the phylogeny of platyhelminthes based on partial sequencing of 18S ribosomal DNA
  217. Detection and characterization of DNA polymerase activity in Toxoplasma gondii
  218. Analysis of dinucleotide frequency and codon usage in the phylum Apicomplexa
  219. Ribosomal DNA sequence comparison of Babesia and Theileria
  220. Differences between Leishmania (Leishmania) chagasi, L. (L.) infantum and L. (L.) donovani as shown by DNA fingerprinting
  221. Changes in the messenger RNA population during sporulation of Eimeria maxima
  222. Development of a genetically engineered vaccine against poultry coccidiosis
  223. The phylogenetic relationships of the genus Eimeria based on comparison of partial sequences of 18S rRNA
  224. Eimeria species which infect the chicken contain virus-like RNA molecules
  225. Eimeria species: studies using rRNA and rDNA probes
  226. Cloning of a polymorphic DNA fragment from the genome of Leishmania donovani
  227. Characterisation of a simple, highly repetitive DNA sequence from the parasite Leishmania donovani